Literature DB >> 9710720

Establishment and characterization of "biphenotypic" acute leukemia cell lines with a variant Ph translocation t(9;22;10) (q34;q11;q22).

T Ariyasu1, Y Matsuo, A Harashima, S Nakamura, S Takaba, T Tsubota, K Orita.   

Abstract

We established two novel PH-positive acute leukemia cell lines with "biphenotypic" feature, NALM-27 and NALM-28, with t(9;22;10)(q34;q11;q22) from a patient with biphenotypic acute leukemia(BAL). The breakpoint cluster region (bcr) of the BCR gene was found to be rearranged in these cells by Southern blot analysis using a major 3'-side bcr probe. Polymerase chain reaction (PCR) results showed differences in the pattern of expression of the abl-bcr fusion gene in comparison with the diagnosis. In the case of variant Ph translocations, reports have appeared concerning mainly chronic myelogenous leukemia (CML), but there have been few concerning acute leukemia with lymphoid feature. This study thus identifies nonrandomly involved chromosome sites which can then be targeted for detailed molecular analysis to obtain an understanding of abl-bcr fusion in the cells with lymphoid feature. In addition, chromosome band 10q22, involved in this translocation, is the site for several neoplasia. Furthermore, this site is non-randomly involved in the formation of variant Ph translocations in acute lymphoblastic leukemia (ALL). This is the first report on the t(9;22;10)(q34;q11;q22) rearrangement in NALM-27 and NALM-28 cell lines which should prove useful for understanding the translocation of molecular breaks within the bcr of the complex translocation site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710720

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  6 in total

1.  Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.

Authors:  Chihiro Tomoyasu; Toshihiko Imamura; Toshihiro Tomii; Mio Yano; Daisuke Asai; Hiroaki Goto; Akira Shimada; Masashi Sanada; Shotaro Iwamoto; Junko Takita; Masayoshi Minegishi; Takeshi Inukai; Kanji Sugita; Hajime Hosoi
Journal:  Int J Hematol       Date:  2018-05-21       Impact factor: 2.490

2.  Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.

Authors:  Nana Ping; Huiying Qiu; Qian Wang; Haiping Dai; Changgeng Ruan; Stefan Ehrentraut; Hans G Drexler; Roderick A F MacLeod; Suning Chen
Journal:  J Hematol Oncol       Date:  2015-08-21       Impact factor: 17.388

3.  Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.

Authors:  Kazuya Takahashi; Takeshi Inukai; Toshihiko Imamura; Mio Yano; Chihiro Tomoyasu; David M Lucas; Atsushi Nemoto; Hiroki Sato; Meixian Huang; Masako Abe; Keiko Kagami; Tamao Shinohara; Atsushi Watanabe; Shinpei Somazu; Hiroko Oshiro; Koshi Akahane; Kumiko Goi; Jiro Kikuchi; Yusuke Furukawa; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Kanji Sugita
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

4.  NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells.

Authors:  Shinpei Somazu; Yoichi Tanaka; Minori Tamai; Atsushi Watanabe; Keiko Kagami; Masako Abe; Daisuke Harama; Tamao Shinohara; Koshi Akahane; Kumiko Goi; Kanji Sugita; Takaya Moriyama; Jun Yang; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Junko Takita; Takeshi Inukai
Journal:  J Cell Mol Med       Date:  2021-10-12       Impact factor: 5.310

5.  Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.

Authors:  Hilmar Quentmeier; Claudia Pommerenke; Hans G Drexler
Journal:  Curr Issues Mol Biol       Date:  2021-11-30       Impact factor: 2.976

6.  Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.

Authors:  Tamao Shinohara; Kevin Y Urayama; Atsushi Watanabe; Koshi Akahane; Kumiko Goi; Meixian Huang; Keiko Kagami; Masako Abe; Kanji Sugita; Yukinori Okada; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Takeshi Inukai
Journal:  J Cell Mol Med       Date:  2020-10-01       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.